Untersuchungen zur Struktur und biologischen Aktivität von ...

LITERATURVERZEICHNIS
_____________________________________________________________________
248 Schwebach JR, Glatman-Freedman A, Gunther-Cummins L, Dai Z, Robbins JB, Schneerson R,
Casadevall A. Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro
and in vivo. Infect Immun. 2002;70:2566-2575.
249 Zlotta AR, Van Vooren JP, Denis O, Drowart A, Daffé M, Lefevre P, Schandene L, De Cock M,
De Bruyn J, Vandenbussche P, Jurion F, Palfliet K, Simon J, Schulman CC, Content J, Huygen K. What
are the immunologically active components of bacille Calmette-Guérin in therapy of the superficial
bladder cancer? Int J Cancer. 2000;87:844-852.
250 Huang TC. Management of complications of bacillus Calmette-Guérin immunotherapy in the treatment
of bladder cancer. Ann Pharmacother 2000;34:529-532.
251 Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guérin
immunotherapy in 1278 patients with bladder cancer. J Urol. 1986;135:272-274.
252 Sänger C, Busche A, Bentin G, Spallek R, Jonas F, Böhle A, Singh M, Brandau S. Immunodominant
PstS1 antigen of Mycobacterium tuberculosis is a potent biological response modifier for the treatment of
bladder cancer. BMC Cancer. 2004;4:86.
253 Dinadayala P, Lemassu A, Granovski P, Cératola S, Winter N, Daffé M. Revisiting the structure of
the anti-neoplastic glucans of Mycobacterium bovis bacille Calmette-Guérin. J Biol Chem. 279;12369-
12378.
254 Teitelbaum R, Glatman-Freedman B, Chen B, Robbins J, Unanue E, Casadevall A, Bloom BR. A
monoclonal antibody recognizing a surface antigen of Mycobacterium tuberculosis enhances host
survival. Proc Natl Acad Sci USA. 1998;95:15688-15693.
255 Glatman-Freedman B, Mednick AJ, Lendvai N, Casadevall A. Monoclonal antibodies to surface
antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot
assay for detection of mycobacteria. J Clin Microbiol. 1996;34:2795-2802.
256 Schwebach JR, Casadevall A, Schnerson R, Dai Z, Wang X, Robbins JB, Glatman-Freedman A.
Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect Immun.
2001;69:5671-5678.
257 Weber PL, Gray GR. Structural and immunochemical characterization of the acidic arabinomannan
of Mycobacterium smegmatis. Carbohydr. Res. 1979;74:259-278.
258 Lemassu A, Daffé M. Structural features of the exopolysaccharides of Mycobacterium tuberculosis.
Biochem J. 1994;297:351-357.
259 Daffé M, Brennan PJ, McNeil M. Predominant structural features of the cell wall arabinogalactan of
Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by
gas chromatography/mass spectrometry and by 1 H-NMR and 13 C-NMR analyses. J Biol Chem.
1990;265:6734-6743.
260 Daffé M, Brennan PJ, McNeil M. Major structural features of the cell wall arabinogalactans of Mycobacterium,
Rhodococcus, and Nocardia spp. Carbohydr Res. 1993;249:383-398.
261 Cole ST, Brosch R, Parkill J, Garnier T, Curcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry
CE 3 rd , Tekaia F, Badcock K, Besham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K,
Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Kroghs A, McLean J, Moule S,
Murphy L, Oliver K, Osbourne J, Quail MA, Rajandream MA, Rogers JR, Sutter S, Seeger K, Skelton J,
Squares R, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium
tuberculosis from the complex genome sequence. Nature. 1998;393:537-544.
262 Rosenkrands I, King A, Weldingh K, Moniatte M, Moertz E, Andersen P. Towards the proteome of
Mycobacterium tuberculosis. Electrophoresis. 2000;21:3740-3756.
190